Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:18 PM
Ignite Modification Date:
2025-12-24 @ 7:18 PM
NCT ID:
NCT01755403
Eligibility Criteria:
Inclusion Criteria:
* Adult patients with Chronic Chagas Disease diagnosed by 2 different and positive serological tests.
* Patients with Chronic Chagas Disease who are going to start treatment with Benznidazole.
* Any gender.
* All the participants must agree to participate in the study and must sign the informed consent.
Exclusion Criteria:
* Patients younger than 18.
* Patients with previous hypersensitivity to Benznidazole.
* Immunocompromised patients as AIDS, cancer, chemotherapy, longterm corticoids need, primary immunodeficiency, or any other.
* Hepatic dysfunction
* Renal dysfunction: serum creatinin higher than 3 mg/dl.
* Pregnancy or lactation.
* Low adhesion to treatment or check-up.
* Impossibility of follow-up.
* Severe adverse reaction to Benznidazole.
* Any other situation that could be risky for the patient.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT01755403
Study Brief:
Protocol Section:
NCT01755403